The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
Approval Biosimilar Notice Implicates Millions
1 min
Related Services
Related Insights
Venable Fitzpatrick’s BiologicsHQ Monthly Injection – September 2021
Venable Fitzpatrick’s BiologicsHQ Monthly Injection – September 2021
October 12, 2021
1min
Senator Leahy Introduces the Restoring the America Invents Act, Ending Discretionary Denials at the PTAB
Senator Leahy Introduces the Restoring the America Invents Act, Ending Discretionary Denials at the PTAB
October 01, 2021
5min
FDA and USPTO Collaboration to Increase Pharmaceutical Competition
FDA and USPTO Collaboration to Increase Pharmaceutical Competition
October 01, 2021
3min
Events
Most Valuable Player: Monetizing & Protecting Your Brand For Athletes, Influencers, and Sponsors
Most Valuable Player: Monetizing & Protecting Your Brand For Athletes, Influencers, and Sponsors
October 19, 2021
ACC Virtual Annual Meeting 2021
ACC Virtual Annual Meeting 2021
October 19 - 22, 2021
Recent News
Craig Thompson Once Again Recognized Among Benchmark Litigation’s Top 100 Trial Lawyers
Craig Thompson Once Again Recognized Among Benchmark Litigation’s Top 100 Trial Lawyers
October 13, 2021
1min
Kids in Need of Defense Recognizes Harrison Taylor as Its Baltimore Pro Bono Advocate of the Year
Kids in Need of Defense Recognizes Harrison Taylor as Its Baltimore Pro Bono Advocate of the Year
October 13, 2021
2min
Law360 Quotes Ashley Craig on the Revival of Limited Exclusions from Tariffs on Chinese Goods
Law360 Quotes Ashley Craig on the Revival of Limited Exclusions from Tariffs on Chinese Goods
October 13, 2021
2min